L5 Capital

L5 Capital appears to refer to an investment firm rather than an operating biotech, pharma, or healthcare company. Publicly available sources point to two similarly named entities: L5 Capital Inc., described in securities filings and databases as Marc Lustig's family office and investment company, and Level 5 Capital Partners, an Atlanta-based private equity firm focused on consumer, wellness, and selected health-related services investments. Neither appears to operate a proprietary therapeutic pipeline, drug-development platform, or clinical-stage program portfolio. The firm's activity is better characterized as investing in and supporting portfolio companies than developing medicines or healthcare products directly. For biotech analyst purposes, this is best treated as a financial sponsor/investment entity with some exposure to health, wellness, and life-science-adjacent investments rather than a life sciences operating company.